logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: Transcription factor p65

UniprotKB/SwissProt ID: TF65_HUMAN (Q04206)

Gene Name: RELA

Synonyms: NFKB3

Organism: Homo sapiens (Human).

Function: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Nucleus. Cytoplasm. Note=Colocalized with DDX1 in the nucleus upon TNF-alpha induction (By similarity). Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B). Colocalizes with GFI1 in the nucleus after LPS sti

PDB :
( If your security settings prevent Jmol from running, please register http://140.138.144.145/ as a safe location in your Java settings. )

Network with metabolic pathway:
Kegg map ID Pathway Link
map05030Cocaine addiction
map05120Epithelial cell signaling in Helicobacter pylori infection
map05131Shigellosis
map05134Legionellosis
map05221Acute myeloid leukemia
map04064NF-kappa B signaling pathway
map04066HIF-1 signaling pathway
map04210Apoptosis
map04380Osteoclast differentiation
map04621NOD-like receptor signaling pathway
map04622RIG-I-like receptor signaling pathway
map04623Cytosolic DNA-sensing pathway
map04660T cell receptor signaling pathway
map04662B cell receptor signaling pathway
map04722Neurotrophin signaling pathway
map04920Adipocytokine signaling pathway
map05133Pertussis
map05140Leishmaniasis
map05142Chagas disease (American trypanosomiasis)
map05145Toxoplasmosis
map05146Amoebiasis
map05160Hepatitis C
map05162Measles
map05212Pancreatic cancer
map05215Prostate cancer
map05220Chronic myeloid leukemia
map05222Small cell lung cancer
map04010MAPK signaling pathway
map04062Chemokine signaling pathway
map04151PI3K-Akt signaling pathway
map04620Toll-like receptor signaling pathway
map05132Salmonella infection
map05152Tuberculosis
map05161Hepatitis B
map05164Influenza A
map05166HTLV-I infection
map05168Herpes simplex infection
map05169Epstein-Barr virus infection
map05200Pathways in cancer
map05202Transcriptional misregulation in cancer
map05203Viral carcinogenesis
Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR000451
IPR002909
IPR008967
IPR011539
IPR013783
IPR014756

3D Structure Databases:
3D structure databases
EntryMethodResolution (A)ChainPositionsView
1NFI X-ray 2.70 A A/C20-320Link
2LSP NMR - A304-316Link
2O61 X-ray 2.80 A A20-291Link
3GUT X-ray 3.59 A A/C/E/G20-291Link
3QXY X-ray 2.09 A P/Q302-316Link
3RC0 X-ray 2.19 A P/Q302-316Link
4KV1 X-ray 1.50 A C/D308-314Link
4KV4 X-ray 2.00 A B308-314Link

The S-nitrosylation sites of TF65_HUMAN

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
138KQRGMRFRYK C EGRSAGSIPG CCCCCEEEEE E CCCCCCCCCC 5.06%HC0222178444-
238KQRGMRFRYK C EGRSAGSIPG CCCCCEEEEE E CCCCCCCCCC 5.06%HC0217720813-